| Specimen Type | Type of Container | Volume of Specimen | Status |
|---|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Bone marrow | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
Submission of a completed BMT Engraftment/Chimerism Test Requisition Form is required. Submission of BOTH the Recipient and Donor samples are required for this test. Please collect recipient sample PRIOR to pre-transplant treatment. For donor samples, please label with two unique donor idenfiers such as donor name and donor DOB, or two ID numbers associated wtih the donor if anonymous donor from the donor registry is used. If the donor sample is submitted separately from the recipient sample, please submit the donor sample accompanied by the requisition form completed with both the donor and recipient information. All samples should be labeled with specimen type (e.g. blood, bone marrow, stem cells). Please provide expected date of transplant on the requisition from.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
| Specimen Type | Type of Container | Volume of Specimen | Status |
|---|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Bone marrow | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Specimen Type | Type of Container | Minimum Volume |
|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 3 mL |
| Bone marrow | 4 mL Purple tube (EDTA) | 3 mL |
Submission of a completed BMT Engraftment/Chimerism Test Requisition Form is required. Submission of BOTH the Recipient and Donor samples are required for this test. Please collect recipient sample PRIOR to pre-transplant treatment. For donor samples, please label with two unique donor idenfiers such as donor name and donor DOB, or two ID numbers associated wtih the donor if anonymous donor from the donor registry is used. If the donor sample is submitted separately from the recipient sample, please submit the donor sample accompanied by the requisition form completed with both the donor and recipient information. All samples should be labeled with specimen type (e.g. blood, bone marrow, stem cells). Please provide expected date of transplant on the requisition from.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
| Specimen Type | Type of Container | Volume of Specimen | Status |
|---|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Bone marrow | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Specimen Type | Type of Container | Minimum Volume |
|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 3 mL |
| Bone marrow | 4 mL Purple tube (EDTA) | 3 mL |
Submission of a completed BMT Engraftment/Chimerism Test Requisition Form is required. Submission of BOTH the Recipient and Donor samples are required for this test. Please collect recipient sample PRIOR to pre-transplant treatment. For donor samples, please label with two unique donor idenfiers such as donor name and donor DOB, or two ID numbers associated wtih the donor if anonymous donor from the donor registry is used. If the donor sample is submitted separately from the recipient sample, please submit the donor sample accompanied by the requisition form completed with both the donor and recipient information. All samples should be labeled with specimen type (e.g. blood, bone marrow, stem cells). Please provide expected date of transplant on the requisition from.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
| Outpatient Requirements |
| Specimen Type | Type of Container | Volume of Specimen | Status |
|---|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Bone marrow | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
Submission of a completed BMT Engraftment/Chimerism Test Requisition Form is required. Submission of BOTH the Recipient and Donor samples are required for this test. Please collect recipient sample PRIOR to pre-transplant treatment. For donor samples, please label with two unique donor idenfiers such as donor name and donor DOB, or two ID numbers associated wtih the donor if anonymous donor from the donor registry is used. If the donor sample is submitted separately from the recipient sample, please submit the donor sample accompanied by the requisition form completed with both the donor and recipient information. All samples should be labeled with specimen type (e.g. blood, bone marrow, stem cells). Please provide expected date of transplant on the requisition from.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
| Inpatient Requirements |
| Specimen Type | Type of Container | Volume of Specimen | Status |
|---|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Bone marrow | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Specimen Type | Type of Container | Minimum Volume |
|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 3 mL |
| Bone marrow | 4 mL Purple tube (EDTA) | 3 mL |
Submission of a completed BMT Engraftment/Chimerism Test Requisition Form is required. Submission of BOTH the Recipient and Donor samples are required for this test. Please collect recipient sample PRIOR to pre-transplant treatment. For donor samples, please label with two unique donor idenfiers such as donor name and donor DOB, or two ID numbers associated wtih the donor if anonymous donor from the donor registry is used. If the donor sample is submitted separately from the recipient sample, please submit the donor sample accompanied by the requisition form completed with both the donor and recipient information. All samples should be labeled with specimen type (e.g. blood, bone marrow, stem cells). Please provide expected date of transplant on the requisition from.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
| Overview/Billing |
| Interpretation |
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
| NCH Lab Only |
| Specimen Type | Type of Container | Volume of Specimen | Status |
|---|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Bone marrow | 4 mL Purple tube (EDTA) | 4 mL-8 mL | Preferred |
| Specimen Type | Type of Container | Minimum Volume |
|---|---|---|
| Whole blood | 4 mL Purple tube (EDTA) | 3 mL |
| Bone marrow | 4 mL Purple tube (EDTA) | 3 mL |
Submission of a completed BMT Engraftment/Chimerism Test Requisition Form is required. Submission of BOTH the Recipient and Donor samples are required for this test. Please collect recipient sample PRIOR to pre-transplant treatment. For donor samples, please label with two unique donor idenfiers such as donor name and donor DOB, or two ID numbers associated wtih the donor if anonymous donor from the donor registry is used. If the donor sample is submitted separately from the recipient sample, please submit the donor sample accompanied by the requisition form completed with both the donor and recipient information. All samples should be labeled with specimen type (e.g. blood, bone marrow, stem cells). Please provide expected date of transplant on the requisition from.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
Bone marrow engraftment analysis, also known as chimerism testing, involves determining the percentage of donor cells present in the recipient sample after allogeneic bone marrow transplant (BMT) or hematopoietic stem cell transplant (HSCT). Engraftment monitoring after BMT/HSCT is critical to assess the outcome of transplant and to predict the risk of relapse. Quantitative analysis of polymorphic genetic markers has become the standard technique for engraftment analysis due to its high sensitivity. Pre-transplant bone marrow engraftment analysis determines the polymorphic genetic markers in the recpieint and donor samples, so these genotypes will be available after the transplant for post-transplant engraftment analysis to be done on patient sample. Therefore, donor and recipient specimens must be obtained and genotyped before the transplant event occurs.
Please call the Institute for Genetics Medicine Clinical Laboratory at (614) 722-5321 with questions.
